A slower ramp-up of Kisunla dosing lowers the rate of dangerous brain swelling, a risk that has made doctors reluctant to ...

In this week’s edition of InnovationRx, we look at Immuneering’s slow-and-steady approach to cancer fighting, litigation over ...

In this episode of Sagebrushers, University of Nevada, Reno President Brian Sandoval speaks with Associate Professor for Public Health Jennifer Pearson. Pearson provides insight surrounding ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

Inovio Pharmaceuticals (NASDAQ:INO) stock rises as Piper Sandler issues new Overweight rating, citing FDA approval for its lead drug INO-3107 next year. Read more here.

South Carolina cooks may want to be extra cautious when cooking meat after considering a new report that showed more than a ...

Aktiia, a pioneer in continuous blood pressure monitoring, has secured FDA 510(k) clearance for its medical-grade G0 Blood ...

Mondelēz recalls four Ritz peanut butter cracker sandwich varieties nationwide due to mislabeling that could trigger ...

In what experts are calling a “dream come true,” scientists used a recent biochemical discovery to help an 8-year-old boy ...

Researchers from the University of Georgia found a new drug that may boost the brain's ability to heal itself after injury.

Some Ritz peanut butter cracker sandwiches are being recalled because the individually wrapped packs may be incorrectly ...

Stoboclo and Osenvelt, FDA-approved biosimilars of Prolia and Xgeva, are now available in the U.S. for variois cancers and ...